JPRN-UMIN000010261尚未招募未知
Multi-center cooperative clinical study on the renoprotective effect of DPP-4 inhibitor (Vildagliptin) in Diabetic nephropathy patients - Clinical study on the renoprotective effect of DPP-4 inhibitor (Vildagliptin) in Diabetic nephropathy patients
Faculty of Medicine, Kagawa University0 个研究点目标入组 40 人开始时间: 2013年3月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with contraindications for Vildagliptin 2) Patients participating in other clinical trials 3) Women during pregnancy, after childbirth, on breastfeeding, or with the possibility of being pregnant. 4) Patients with other severe complications 5) Patients judged inadequate for other reasons by doctors
研究者
相似试验
进行中（未招募）
不适用
Prospective, multicenter study to evaluate the renal safety of 6 mg ibandronic acid infusions over 15 min or 60 min in patients with metastatic bone disease due to breast cancer.The target population for this trial are female patients with primary breast cancer with metastatic bone disease.EUCTR2005-000535-18-DERoche Pharma (Schweiz) AG130
已完成
不适用
Multicenter cooperative observational study of reactivation of hepatitis B virus caused by everolimus or sorafenibJPRN-UMIN000005370Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East100
已完成
不适用
Multicenter cooperative observational study of reactivation of hepatitis B virus caused by anticancer treatments for solid tumorsSolid tumor patients with seropositivity for HBsAg, or seronegativity for HBsAg and seropositivity for HBcAb and/or HBsAb, receiving first chemotherapy including neoadjuvant and adjuvant chemotherapy.JPRN-UMIN000005369Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East300
已完成
不适用
Multicenter collaborative retrospective study of POEM for achalasiaAchalasia and esophageal motility disordersJPRN-UMIN000037513Digestive Diseases Center, Showa University Koto-Toyosu Hospital2,000
招募中
Unknown
A Prospective Multi-Center RCT Assessing Clinical Efficacy and Safety of the CE-marked Untire App®, Targeting Breast Cancer Patients (ICD-10 C50) with Cancer-Related Fatigue in the Post-Primary Treatment Phase of their Cancer, Powered to Detect Significant Fatigue Improvement (Untire-III-B)C50Malignant neoplasm of breastDRKS00031951Tired of Cancer B.V.184